Discover the full record of transactions filed by MULLEN JAMES C, Chairman & CEO. Insider active across 2 companies, notably Thermo Fisher Scientific INC.. In total, 11 reports have been published. Total volume traded: €1.8m. The latest transaction was disclosed on 18 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
James C. Mullen is the Chairman & CEO of Thermo Fisher Scientific Inc. and Editas Medicine, Inc. He oversees the strategic operations and overall direction of these companies. With extensive experience in the industry, Mullen is recognized for his leadership in developing innovative solutions and advanced technologies. His role also involves managing stakeholder relationships and promoting sustainable growth within his organizations.